Medicine:Bioclipse
Developer(s) | The Bioclipse Project |
---|---|
Initial release | 17 November 2005[1] |
Stable release | 2.6.2 (November 4, 2016[±] | )
Type | Cheminformatics, bioinformatics |
License | Eclipse Public License |
The Bioclipse project is a Java-based, open-source, visual platform for chemo- and bioinformatics based on the Eclipse Rich Client Platform (RCP).[2][3]
About
Biclipse gained scripting functionality in 2009,[4] and a command line version in 2021.[5]
Like any RCP application, Bioclipse uses a plugin architecture that inherits basic functionality and visual interfaces from Eclipse, such as help system, software updates, preferences, cross-platform deployment etc. Via its plugins, Bioclipse provides functionality for chemo- and bioinformatics, and extension points that easily can be extended by other, possibly proprietary, plugins to provide additional functionality.
Product
The first stable release of Bioclipse includes a Chemistry Development Kit (CDK) plugin to provide a chemoinformatic backend, a Jmol plugin for 3D-visualization of molecules, and a BioJava plugin for sequence analysis. Recently, the R platform, using StatET,[6] and OpenTox were added.[7]
Bioclipse is developed as a collaboration between the Proteochemometric Group, Dept. of Pharmaceutical Biosciences, Uppsala University, Sweden, the Christoph Steinbeck Group at the European Bioinformatics Institute, and the Analytical Chemistry Department at Leiden University, but also includes extensions developed at other academic institutes, including the Karolinska Institutet and Maastricht University.[8] The development is backed up by the International Bioclipse Association.[9]
Bioclipse Scripting Language
The Bioclipse Scripting Language (BSL) is a scripting environment, currently based on JavaScript and Groovy. It extends the scripting language with managers that wrap the functionality of third party libraries, as mentioned above. These scripts thus provide means to make analyses in Bioclipse sharable, for example, on MyExperiment.org. Bioclipse defines a number of core data types that managers support, allowing information to be used between these managers.
References
- ↑ "Bioclipse - Browse /Bioclipse at SourceForge.net". https://sourceforge.net/projects/bioclipse/files/bioclipse/.
- ↑ Ola Spjuth, Tobias Helmus, Egon L Willighagen, Stefan Kuhn, Martin Eklund, Johannes Wagener, P. Murray-Rust, Christoph Steinbeck, Jarl E.S. Wikberg, Bioclipse: An open source workbench for chemo- and bioinformatics, BMC Bioinformatics, 2007, 8. doi:10.1186/1471-2105-8-59
- ↑ Hasan, Mehedi (2023-01-24). "20 Best Bioinformatics Tools for Linux Systems" (in en-US). https://www.ubuntupit.com/best-bioinformatics-tools-for-linux-an-ultimate-collection/.
- ↑ Ola Spjuth, Jonathan Alvarsson, Arvid Berg, Martin Eklund, Stefan Kuhn, Carl Mäsak, Gilleain Torrance, Johannes Wagener, Egon L Willighagen, Christoph Steinbeck, and Jarl ES Wikberg, Bioclipse 2: A scriptable integration platform for the life sciences, BMC Bioinformatics, 2009, 10, doi:10.1186/1471-2105-10-397
- ↑ Willighagen, Egon (23 June 2021). "Bacting: a next generation, command line version of Bioclipse". Journal of Open Source Software 6 (62): 2558. doi:10.21105/joss.02558. Bibcode: 2021JOSS....6.2558W.
- ↑ Spjuth, O.; Georgiev, V.; Carlsson, L.; Alvarsson, J.; Berg, A.; Willighagen, E.; Wikberg, J. E. S.; Eklund, M. (2012). "Bioclipse-R: Integrating management and visualization of life science data with statistical analysis". Bioinformatics 29 (2): 286–289. doi:10.1093/bioinformatics/bts681. PMID 23178637.
- ↑ Willighagen, E. L.; Jeliazkova, N.; Hardy, B.; Grafström, R. C.; Spjuth, O. (2011). "Computational toxicology using the OpenTox application programming interface and Bioclipse". BMC Research Notes 4: 487. doi:10.1186/1756-0500-4-487. PMID 22075173.
- ↑ "Bioclipse Labs". http://wiki.bioclipse.net/index.php?title=Category:BioclipseLabs.
- ↑ Uppsala University Pressmedelanden: Dubbla utmärkelser för IT/bioteknik-system
External links
Original source: https://en.wikipedia.org/wiki/Bioclipse.
Read more |